Evaluating the Safety and Efficacy of SGLT-2 Inhibitors on Reducing Cardiovascular and Renal Mortality, Morbidity and Inflammatory Outcomes in Various Patient Populations: A Systematic Review and Meta-Analysis of 92 920 Patients
Syed Hamza Haider, Areeka Irfan, Samir Mustafa Sheikh, Muhammad Omar Larik, Ali Raza, Yumna Khabir
- ISSN / E-ISSN
- — / —
- DOI
- 10.1177/11795468251347777 ↗
- Volume · Issue · Pages
- 19 · — · 11795468251347777-11795468251347777
- Publisher
- Libertas Academica Ltd.
- Article URL
- https://doi.org/10.1177/11795468251347777 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
30 Jun 2025
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 30 Jun 2025 | OpenAlex |
Keywords (as given): SGLT2 inhibitors; cardiovascular mortality; renal mortality; heart failure; renal replacement therapy; inflammatory markers; interleukin-6; TNF-α; blood pressure; flow-mediated dilation; dyslipidemia; amputation; fracture; diabetes mellitus; chronic kidney disease
HEC Status at Publication Not the journal's current status
HEC Status at PublicationNot conclusive
Historical status could not be conclusively determined.
- Some rows of the HEC list for this period are not yet matched to a journal, so absence cannot be proved. Pending verification.
Best available information, not a definitive status: Some rows of the HEC list for this period are not yet matched to a journal, so absence cannot be proved. Pending verification.
- Journal
- Clinical Medicine Insights: Cardiology
- Publication date used
- 30 Jun 2025 (OpenAlex publication date)
- Applicable HEC period
- 2024–25 (version 1) · 01 Oct 2024 – 31 Mar 2026
- Category
- —
- Recognition status
- Pending Verification (PERIOD_HAS_UNMATCHED_ROWS)
- Source
- —
- Verification status
- Unverified
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.